Dashboard
Manage Tickers

BCDA BioCardia, Inc.

Nasdaq biocardia.com


$ 1.22 $ -0.03 (-2.38 %)    

Friday, 14-Nov-2025 15:48:43 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 1.23
$ 1.25
$ 1.22 x 805
$ 1.23 x 1,157
$ 1.23 - $ 1.23
$ 1.00 - $ 3.20
60,125
na
13.05M
$ 1.18
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-12-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
3 05-14-2025 03-31-2025 10-Q
4 03-26-2025 12-31-2024 10-K
5 11-13-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-14-2024 03-31-2024 10-Q
8 03-27-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-10-2023 03-31-2023 10-Q
12 03-29-2023 12-31-2022 10-K
13 11-09-2022 09-30-2022 10-Q
14 08-10-2022 06-30-2022 10-Q
15 05-11-2022 03-31-2022 10-Q
16 03-29-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
19 05-13-2021 03-31-2021 10-Q
20 03-30-2021 12-31-2020 10-K
21 11-10-2020 09-30-2020 10-Q
22 08-13-2020 06-30-2020 10-Q
23 05-15-2020 03-31-2020 10-Q
24 04-09-2020 12-31-2019 10-K
25 11-19-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 04-02-2019 12-31-2018 10-K
29 11-08-2018 09-30-2018 10-Q
30 08-09-2018 06-30-2018 10-Q
31 05-10-2018 03-31-2018 10-Q
32 03-16-2018 12-31-2017 10-K
33 11-09-2017 09-30-2017 10-Q
34 08-14-2017 06-30-2017 10-Q
35 05-11-2017 03-31-2017 10-Q
36 03-30-2017 12-31-2016 10-K
37 10-17-2016 09-30-2016 10-Q
38 08-02-2016 06-30-2016 10-Q
39 05-03-2016 03-31-2016 10-Q
40 03-25-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

biocardia-q3-eps-024-beats-025-estimate
BioCardia Q3 EPS $(0.24) Beats $(0.25) Est...
11/12/2025 21:13:00

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.25) by ...

earnings-scheduled-for-november-12-2025
Earnings Scheduled For November 12, 2025
11/12/2025 11:11:28

earnings-outlook-for-biocardia
Earnings Outlook For BioCardia
11/11/2025 18:03:22

biocardia-announces-first-patient-enrolled-at-henry-ford-health-in-ongoing-phase-3-cardiamp-hf-ii-clinical-trial-for-patients-with-ischemic-heart-failure-of-reduced-ejection-fraction
BioCardia Announces First Patient Enrolled...
11/10/2025 13:31:55

biocardia-announces-university-of-wisconsin-enrolled-first-patient-in-phase-3-cardiamp-hf-ii-cell-therapy-pivotal-trial
BioCardia Announces University Of Wisconsi...
10/30/2025 12:04:56

biocardia-updates-atm-offering-raising-maximum-aggregate-sale-to-5309253
BioCardia Updates ATM Offering, Raising Ma...
10/24/2025 20:26:36

This prospectus supplement updates and amends certain information in our base prospectus, dated December 5, 2023, as supplement...

biocardia-regains-compliance-with-nasdaq-listing-requirements
BioCardia Regains Compliance With Nasdaq L...
10/02/2025 12:04:10

BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pu...

hc-wainwright--co-reiterates-buy-on-biocardia-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on BioC...
09/22/2025 16:19:33

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

biocardia-held-preliminary-clinical-consultation-with-japans-pharmaceutical-and-medical-device-agency-on-its-cardiamp-heart-failure-trial-results
BioCardia Held Preliminary Clinical Consul...
09/22/2025 12:14:28

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/18/2025 17:06:02

gold-falls-over-1-darden-posts-downbeat-earnings
Gold Falls Over 1%; Darden Posts Downbeat ...
09/18/2025 16:27:56

nasdaq-surges-100-points-bionano-genomics-shares-plunge
Nasdaq Surges 100 Points; Bionano Genomics...
09/18/2025 13:59:31

biocardia-prices-public-offering-of-48m-shares-and-warrants-at-a-combined-price-of-125-for-up-to-12m-in-gross-proceeds
BioCardia Prices Public Offering Of 4.8M S...
09/18/2025 13:21:18

BioCardia®, Inc. (NASDAQ:BCDA) ("BioCardia" or the "Company"), a developer of cellular and cell-derived therape...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/18/2025 12:09:24

biocardia-announces-primary-endpoint-results-of-open-label-roll-in-cohort-of-cardiamp-cell-therapy-in-chronic-myocardial-ischemia-trial
BioCardia Announces Primary Endpoint Resul...
09/18/2025 11:02:52

BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pu...

biocardia-inc-files-for-offering-of-up-to-28m-shares-of-common-stock-together-with-up-to-28m-common-warrants
Biocardia Inc Files For Offering Of Up To ...
09/16/2025 13:49:53

- SEC Filing

biocardia-and-cart-tech-announce-exclusive-partnership-for-development-and-commercialization-of-heart3d-system-for-fusion-imaging
BioCardia And CART-Tech Announce Exclusive...
08/13/2025 12:06:53

biocardia-q2-eps-040-beats-050-estimate
BioCardia Q2 EPS $(0.40) Beats $(0.50) Est...
08/11/2025 13:17:58

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.50) by ...

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

biocardia-provides-expected-timing-for-regulatory-activities-for-fda-and-japan-pmda-approvals-of-its-cardiamp-cell-therapy-system-and-helix-transendocardial-delivery-catheter
Biocardia Provides Expected Timing For Reg...
08/04/2025 10:02:37

Q3 2025 Helix application for approval to FDAThe Company intends to submit for approval of the Helix Transendocardial Delivery ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION